This 10/23/2026 titled “Development and internal validation of the Laboratory-based Liver Frailty Index (Lab-LFI)—a prediction model for frailty in patients with cirrhosis” in Liver Transplantation (AASLD) is worth reading.

It speaks to a blood test that may help identify which people with cirrhosis are physically frail—and at greater risk of poor outcomes.

Frailty means reduced strength and physical reserve, making illness harder to withstand. Measuring it usually requires an in-person assessment. Researchers developed a score called Lab-LFI, using seven blood biomarkers to estimate frailty.

They found:

  • About 1 in 5 of the 527 patients with cirrhosis were frail.
  • The blood score distinguished frail from nonfrail patients reasonably well, with a statistical performance score of 0.80. This does not mean “80% accurate.”
  • Patients classified as high risk had a 77% higher hazard of death before transplant or dropping off the transplant waiting list, even after accounting for liver disease severity and cause.

The limitation: Researchers developed and tested the score within the same study population. Independent validation is still needed; this study does not establish it as a replacement for physical assessment.